Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,789,394 papers from all fields of science
Search
Sign In
Create Free Account
CS 706
Known as:
TG01
, CS706 cpd
, TP2001
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
apricoxib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Antibacterial Activity of Fruiting Body Extracts from Culinary-Medicinal Winter Mushroom, Flammulina velutipes (Agaricomycetes) against Oral Pathogen Streptococcus mutans.
C. Cui
,
Hui Xu
,
+6 authors
Shujie Cheng
International Journal of Medicinal Mushrooms
2020
Corpus ID: 214079127
The edible medicinal mushroom Flammulina velutipes (enokitake) has many applications as food and medicine, but its application in…
Expand
2017
2017
A phase I/II trial of TG01/GM-CSF and gemcitabine as adjuvant therapy for treating patients with resected RAS-mutant adenocarcinoma of the pancreas.
D. Palmer
,
S. Dueland
,
J. Valle
,
A. Aksnes
2017
Corpus ID: 80945417
4119Background: TG01 (a mixture of 7 RAS peptides) is an injectable antigen-specific cancer immunotherapy targeted to treat…
Expand
2009
2009
Isolation and Characterization of the Native Entomopathogenic Nematode, Heterorhabditis brevicaudis, and its Symbiotic Bacteria from Taiwan
Feng-Chia Hsieh
,
C. Tzeng
,
Jui-Tang Tseng
,
Y. Tsai
,
M. Meng
,
S. Kao
Current Microbiology
2009
Corpus ID: 9228950
The occurrence of Heterorhabditis brevicaudis (Rhabditida: Heterorhabditidae) and its symbiotic bacteria, Photorhabdusluminescens…
Expand
2009
2009
Apricoxib, a COX-2 inhibitor for the potential treatment of pain and cancer.
P. Rao
,
R. Grover
IDrugs : the investigational drugs journal
2009
Corpus ID: 9084571
Apricoxib (CS-706), a small-molecule, orally active, selective COX-2 inhibitor, is under development by Tragara Pharmaceuticals…
Expand
2008
2008
Pain relief model for a COX-2 inhibitor in patients with postoperative dental pain.
S. Rohatagi
,
H. Kastrissios
,
+4 authors
D. Salazar
British Journal of Clinical Pharmacology
2008
Corpus ID: 24861548
AIM To develop a pain relief model for a cyclooxygenase (COX)-2 inhibitor, CS-706, that permits prediction of doses for acute…
Expand
2007
2007
Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice
K. Kiguchi
,
L. Ruffino
,
+6 authors
J. DiGiovanni
Molecular Cancer Therapeutics
2007
Corpus ID: 10061231
Biliary tract cancer is still challenging to treat and manage due to its poor sensitivity to conventional therapies and the…
Expand
2007
2007
Covalent Binding of Rofecoxib, but Not Other Cyclooxygenase-2 Inhibitors, to Allysine Aldehyde in Elastin of Human Aorta
Masataka Oitate
,
T. Hirota
,
T. Murai
,
S. Miura
,
T. Ikeda
Drug Metabolism And Disposition
2007
Corpus ID: 26219367
In rats, it has been reported that rofecoxib, a cyclooxygenase-2 (COX-2) inhibitor, reacts with the aldehyde group of allysine in…
Expand
2007
2007
A Randomized, Double-Blind, One-Week Study Comparing Effects of a Novel COX-2 Inhibitor and Naproxen on the Gastric Mucosa
J. Moberly
,
S. Harris
,
+7 authors
K. Truitt
Digestive Diseases and Sciences
2007
Corpus ID: 10026532
CS-706 is a novel cyclooxygenase-2 (COX-2) inhibitor with potent analgesic, anti-inflammatory, and antitumor properties in animal…
Expand
2007
2007
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
J. Moberly
,
Jianbo Xu
,
+5 authors
K. Truitt
Clinical Therapeutics
2007
Corpus ID: 22854768
1988
1988
Conjugates of elliptinium acetate with mouse monoclonal anti‐α‐fetoprotein antibodies or fab fragments: In vitro cytotoxic effects upon human hepatoma cell lines
G. Alberici
,
M. Pallardy
,
+5 authors
P. Gros
International Journal of Cancer
1988
Corpus ID: 42543646
Elliptinium acetate (EA) is a new anti‐cancer compound displaying cytostatic activity against various malignancies including…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE